{"id":9337,"date":"2025-12-17T16:04:29","date_gmt":"2025-12-17T08:04:29","guid":{"rendered":"https:\/\/regask.com\/?p=9337"},"modified":"2025-12-17T16:04:29","modified_gmt":"2025-12-17T08:04:29","slug":"la-ue-anuncia-una-reforma-historica-de-la-legislacion-farmaceutica","status":"publish","type":"post","link":"https:\/\/regask.com\/es\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/","title":{"rendered":"La UE anuncia una reforma hist\u00f3rica de la legislaci\u00f3n farmac\u00e9utica\u2026"},"content":{"rendered":"<p>El 11 de diciembre de 2025, el <strong><a href=\"https:\/\/commission.europa.eu\/index_en\">Comisi\u00f3n Europea<\/a> <\/strong>anunci\u00f3 un acuerdo pol\u00edtico sobre un <strong>importante reforma de la legislaci\u00f3n farmac\u00e9utica de la UE<\/strong>, lo que supone la revisi\u00f3n m\u00e1s significativa del marco en m\u00e1s de 20 a\u00f1os. La actualizaci\u00f3n afecta <strong>partes interesadas en todo el ecosistema farmac\u00e9utico<\/strong>, incluidos fabricantes, reguladores, proveedores de atenci\u00f3n m\u00e9dica y pacientes, y <strong>Tiene como objetivo modernizar las reglas para mejorar la innovaci\u00f3n, la seguridad, el acceso a los medicamentos y la resiliencia del suministro.<\/strong> Todav\u00eda se requiere la adopci\u00f3n formal por parte del Parlamento Europeo y del Consejo antes de que las reformas entren en vigor.<\/p>\n<div class=\"row\"  id=\"row-660216537\">\n\n\t<div id=\"col-1399628711\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-1118834078\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1118834078 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2><span class=\"TextRun MacChromeBold SCXW150983442 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW150983442 BCX0\" data-ccp-parastyle=\"heading 3\">\u00bfQu\u00e9 est\u00e1 cambiando en el marco farmac\u00e9utico de la UE?<\/span><\/span><span class=\"EOP SCXW150983442 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:281,&quot;335559739&quot;:281}\">\u00a0<\/span><\/h2>\n\t<div id=\"gap-762429046\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-762429046 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La reforma actualiza las antiguas normas farmac\u00e9uticas de la UE para reflejar mejor las realidades cient\u00edficas, digitales y de la cadena de suministro actuales.<\/p>\n<p>Se presenta <strong>procedimientos regulatorios simplificados<\/strong> destinado a reducir los plazos de evaluaci\u00f3n para ambos <strong>medicamentos nuevos y gen\u00e9ricos,<\/strong> secundario <a href=\"https:\/\/regask.com\/es\/entrada-al-mercado-de-clasificacion-de-productos\/\">entrada m\u00e1s r\u00e1pida al mercado<\/a> manteniendo al mismo tiempo los est\u00e1ndares de seguridad del paciente.<\/p>\n<p>El acuerdo tambi\u00e9n introduce <strong>entornos de pruebas regulatorios,<\/strong> Proporcionar entornos controlados donde se puedan probar terapias innovadoras de forma segura bajo supervisi\u00f3n regulatoria. Estos entornos de pruebas est\u00e1n dise\u00f1ados para impulsar la innovaci\u00f3n, garantizando al mismo tiempo el cumplimiento de los requisitos de seguridad y calidad.<\/p>\n<p>Para abordar los actuales desaf\u00edos de suministro, la reforma establece un enfoque reforzado para la prevenci\u00f3n y el seguimiento de la escasez, que incluye:<\/p>\n<ul>\n<li>Un nuevo <strong>Marco a nivel de la UE para el seguimiento de la escasez de medicamentos\u00a0<\/strong><\/li>\n<li>Obligaciones m\u00e1s estrictas para las empresas<\/li>\n<li>Mayor coordinaci\u00f3n a trav\u00e9s de la <a href=\"https:\/\/www.ema.europa.eu\/en\/homepage\"><strong>Agencia Europea de Medicamentos (EMA)<\/strong><\/a><\/li>\n<\/ul>\n<p>Paralelamente, la UE establecer\u00e1 una <strong>lista de medicamentos cr\u00edticos,<\/strong> respaldados por evaluaciones de vulnerabilidad para identificar y mitigar los riesgos de suministro.<\/p>\n<p>La reforma aclara adem\u00e1s la aplicaci\u00f3n de la <strong>Exenci\u00f3n de Bolar,<\/strong> permitir a los fabricantes de gen\u00e9ricos preparar su entrada al mercado antes del vencimiento de la patente y apoyar el acceso oportuno a medicamentos asequibles.<\/p>\n<p>Adem\u00e1s, <strong>nuevos incentivos<\/strong> Se introducen productos innovadores que abordan <strong>necesidades m\u00e9dicas no satisfechas,<\/strong> reforzando la ambici\u00f3n de la UE de seguir siendo competitiva en la innovaci\u00f3n farmac\u00e9utica.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1399628711 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1504167528\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Por qu\u00e9 es importante<\/h2>\n\t<div id=\"gap-2033495472\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2033495472 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Esta reforma proporciona mayor <strong>claridad regulatoria,<\/strong> alinea la legislaci\u00f3n farmac\u00e9utica con <strong>innovaci\u00f3n moderna y desarrollo digital,<\/strong> y mejora <strong>eficiencia regulatoria<\/strong> Sin aumentar la carga administrativa innecesaria. Al reforzar la supervisi\u00f3n de la cadena de suministro y acelerar el acceso a los medicamentos, el marco pretende mejorar la seguridad de los pacientes y la resiliencia del sistema en toda la UE.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1504167528 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-360020516\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Para qui\u00e9n es relevante esta actualizaci\u00f3n<\/h2>\n\t<div id=\"gap-1131594143\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1131594143 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Esta actualizaci\u00f3n es relevante para <strong>Asuntos Regulatorios, Garant\u00eda de Calidad, Cadena de Suministro, Acceso al Mercado, I+D, <\/strong>y<strong> Equipos de cumplimiento,<\/strong> as\u00ed como <strong>Equipos de TI y datos<\/strong> Apoyar las operaciones regulatorias y las obligaciones de monitoreo de escasez dentro de las organizaciones farmac\u00e9uticas.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-360020516 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1442661229\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>Pr\u00f3ximos pasos<\/h2>\n\t<div id=\"gap-379827967\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-379827967 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Las partes interesadas deben:<\/p>\n<ul>\n<li><strong>Revisar las l\u00edneas de productos actuales, las estrategias regulatorias y las pr\u00e1cticas de la cadena de suministro.<\/strong> para evaluar la alineaci\u00f3n con los procedimientos simplificados propuestos y los requisitos de monitoreo de escasez<\/li>\n<li><strong>Seguimiento del proceso de aprobaci\u00f3n formal<\/strong> en el Parlamento Europeo y el Consejo<\/li>\n<li>Prep\u00e1rese para adaptar las estrategias de cumplimiento una vez que se confirmen las obligaciones e incentivos finales<\/li>\n<li>A medida que las organizaciones se preparan para estos pr\u00f3ximos cambios, tener una visibilidad estructurada de las normas farmac\u00e9uticas cambiantes de la UE se vuelve cada vez m\u00e1s importante.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/regask.com\/es\/\"><strong>RegASK<\/strong><\/a> <strong>es una plataforma l\u00edder de inteligencia regulatoria y orquestaci\u00f3n de flujos de trabajo con inteligencia artificial de agencia.<\/strong> que permite a las organizaciones globales en sectores altamente regulados, como productos de consumo y ciencias de la vida, navegar proactivamente en entornos regulatorios complejos. Al combinar tecnolog\u00eda avanzada <strong><a href=\"https:\/\/regask.com\/es\/que-es-la-ia-agentica-en-la-inteligencia-de-cumplimiento-normativo\/\">IA agente<\/a> <\/strong>Con expertos en el sector, RegASK ofrece informaci\u00f3n predictiva y procesable oportuna y automatizaci\u00f3n de extremo a extremo, optimizando los procesos de cumplimiento, mitigando riesgos y acelerando el acceso al mercado en todo el mundo. <strong>m\u00e1s de 157 pa\u00edses.\u00a0\u00a0<\/strong><\/p>\n<p><a href=\"https:\/\/regask.com\/es\/producto\/\"><strong>M\u00e1s informaci\u00f3n<\/strong><\/a> o <strong><a href=\"https:\/\/regask.com\/es\/reservar-una-demostracion\/\">Reserve una demostraci\u00f3n ahora.\u00a0<\/a><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1442661229 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1732043313\">\n\n\t<div id=\"col-626612660\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>Preguntas frecuentes<\/h3>\n\t<div id=\"gap-2049634812\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2049634812 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4>\u00bfQu\u00e9 anunci\u00f3 la Comisi\u00f3n Europea el 11 de diciembre de 2025?<\/h4>\n\t<div id=\"gap-1264639965\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1264639965 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La Comisi\u00f3n Europea anunci\u00f3<strong>Acuerdo pol\u00edtico sobre una importante reforma de la legislaci\u00f3n farmac\u00e9utica de la UE,<\/strong> cuyo objetivo es modernizar normas que tienen m\u00e1s de 20 a\u00f1os de antig\u00fcedad.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-626612660 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-403751764\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u00bfCu\u00e1les son los principales objetivos de la reforma farmac\u00e9utica de la UE?<\/h4>\n\t<div id=\"gap-1748732315\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1748732315 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>La reforma pretende <strong>ampliar el acceso a los medicamentos y agilizar los procesos regulatorios,<\/strong> <strong>abordar la escasez de medicamentos, mejorar la seguridad de los pacientes y apoyar la innovaci\u00f3n farmac\u00e9utica.<\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-403751764 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1012747498\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u00bfC\u00f3mo aborda la reforma la escasez de medicamentos en la UE?<\/h4>\n\t<div id=\"gap-486447707\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-486447707 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>Introduce una <strong>Marco de la UE para el seguimiento de la escasez de medicamentos,<\/strong> fortalece las obligaciones de la empresa, mejora <strong>Coordinaci\u00f3n de la EMA,<\/strong> y establece una <strong>lista de medicamentos cr\u00edticos<\/strong> con evaluaciones de vulnerabilidad.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1012747498 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1224610145\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u00bfC\u00f3mo puede RegASK ayudar a los equipos a gestionar el impacto de estos cambios farmac\u00e9uticos de la UE?<\/h4>\n\t<div id=\"gap-425839884\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-425839884 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><a href=\"https:\/\/regask.com\/es\/\">RegASK<\/a> ayuda a los equipos regulatorios y de cumplimiento <strong>Monitorear la evoluci\u00f3n de las regulaciones regulatorias, evaluar el impacto en los productos y las cadenas de suministro, y poner en pr\u00e1ctica las actualizaciones regulatorias<\/strong> a trav\u00e9s de inteligencia impulsada por IA y automatizaci\u00f3n del flujo de trabajo.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1224610145 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On 11 December 2025, the European Commission announced a political agreement on a major reform of EU pharmaceutical legislation, marking the most significant overhaul of the framework in over 20 years. The update affects stakeholders across the pharmaceutical ecosystem, including manufacturers, regulators, healthcare providers, and patients, and aims to modernize rules to improve innovation, safety,&#8230;<\/p>","protected":false},"author":41,"featured_media":9339,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,35],"tags":[],"class_list":["post-9337","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>EU Announces Landmark Reform of Pharmaceutical Regulations<\/title>\n<meta name=\"description\" content=\"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/es\/la-ue-anuncia-una-reforma-historica-de-la-legislacion-farmaceutica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU Announces Landmark Reform of Pharmaceutical Legislation\" \/>\n<meta property=\"og:description\" content=\"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/es\/la-ue-anuncia-una-reforma-historica-de-la-legislacion-farmaceutica\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-17T08:04:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\"},\"headline\":\"EU Announces Landmark Reform of Pharmaceutical Legislat&hellip;\",\"datePublished\":\"2025-12-17T08:04:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\"},\"wordCount\":798,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"articleSection\":[\"Regulatory News\",\"Pharma and Biotech\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\",\"name\":\"EU Announces Landmark Reform of Pharmaceutical Regulations\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"datePublished\":\"2025-12-17T08:04:29+00:00\",\"description\":\"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/eu-announces-landmark-reform-of-pharmaceutical-legislation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/eu-announces-landmark-reform-pharmaceutical-legislation.png\",\"width\":800,\"height\":600,\"caption\":\"Eu Announces Landmark Reform Pharmaceutical Legislation\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\",\"name\":\"Shaffa Renaningtyas\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La UE anuncia una reforma hist\u00f3rica de la normativa farmac\u00e9utica","description":"La UE anuncia una reforma hist\u00f3rica de la legislaci\u00f3n farmac\u00e9utica para mejorar la seguridad y el acceso a los medicamentos para todas las partes interesadas.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/es\/la-ue-anuncia-una-reforma-historica-de-la-legislacion-farmaceutica\/","og_locale":"es_ES","og_type":"article","og_title":"EU Announces Landmark Reform of Pharmaceutical Legislation","og_description":"The EU announces landmark reform of pharmaceutical legislation to enhance safety and access to medicines for all stakeholders.","og_url":"https:\/\/regask.com\/es\/la-ue-anuncia-una-reforma-historica-de-la-legislacion-farmaceutica\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-12-17T08:04:29+00:00","og_image":[{"width":800,"height":600,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Shaffa Renaningtyas","Est. reading time":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#article","isPartOf":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6"},"headline":"EU Announces Landmark Reform of Pharmaceutical Legislat&hellip;","datePublished":"2025-12-17T08:04:29+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/"},"wordCount":798,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","articleSection":["Regulatory News","Pharma and Biotech"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/","url":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/","name":"La UE anuncia una reforma hist\u00f3rica de la normativa farmac\u00e9utica","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","datePublished":"2025-12-17T08:04:29+00:00","description":"La UE anuncia una reforma hist\u00f3rica de la legislaci\u00f3n farmac\u00e9utica para mejorar la seguridad y el acceso a los medicamentos para todas las partes interesadas.","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/eu-announces-landmark-reform-of-pharmaceutical-legislation\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/12\/eu-announces-landmark-reform-pharmaceutical-legislation.png","width":800,"height":600,"caption":"Eu Announces Landmark Reform Pharmaceutical Legislation"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Habilitando decisiones regulatorias m\u00e1s inteligentes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6","name":"Shaffa Renaningtyas"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/comments?post=9337"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/posts\/9337\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media\/9339"}],"wp:attachment":[{"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/media?parent=9337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/categories?post=9337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/es\/wp-json\/wp\/v2\/tags?post=9337"}],"curies":[{"name":"Gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}